- MSKCC’s Dr. Howard I. Scher presented results of a study that showed that targeted therapy improves overall in men with advanced PCa.
- MSKCC will be among 4 different research centers tasked with the mission of solving problems related to mesothelioma and treatment for it.
- Dr. Christopher Park of MSKCC is the lead researcher of a study that supports the theory that myelodysplastic syndromes has its origins in bone marrow stem cells.